Abstract
The present case study describes a co-produced and theoretically informed workshop wherein messages were co-designed to increase the uptake of future COVID-19 vaccines in the United Kingdom. Co-design can enhance the legitimacy and effectiveness of public interventions, but many researchers, service providers, and policymakers may be uncertain where to start. This demonstrative example applies behavioural science and design thinking theory, illustrating how others can integrate theoretically informed co-design into similar and more complex projects efficiently. The workshop brought together members of the public, immunisers, and public health specialists. A narrative analysis was conducted to identify themes related to vaccine hesitancy. The workshop's supporting materials are made available as supplemental materials, which can be modified for future workshops. The discussion encourages additional workshops to be conducted, including diverse members of the public, to co-design novel solutions to improve public health more generally.
Original language | English |
---|---|
Pages (from-to) | 5407-5412 |
Number of pages | 6 |
Journal | Vaccine |
Volume | 40 |
Issue number | 37 |
DOIs | |
Publication status | Published - 2 Sept 2022 |
Bibliographical note
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.Funding Information:
This project was funded as part of the National Institute for Health Research (NIHR) Applied Research Centre (ARC) West Midlands ( NIHR200165 ) and the University of Warwick’s ESRC Impact Acceleration Account fund ( ID ES/T502054/1 ). The views expressed are those of the author(s) and not necessarily the funders. The funders had no role in the design of the study and collection, analysis, and interpretation of data and no role in writing the manuscript.
Funding Information:
This project was funded as part of the National Institute for Health Research (NIHR) Applied Research Centre (ARC) West Midlands (NIHR200165) and the University of Warwick's ESRC Impact Acceleration Account fund (ID ES/T502054/1). The views expressed are those of the author(s) and not necessarily the funders. The funders had no role in the design of the study and collection, analysis, and interpretation of data and no role in writing the manuscript.
Publisher Copyright:
© 2022 The Author(s)
Keywords
- COVID-19 Vaccines
- COVID-19/prevention & control
- Humans
- United Kingdom
- Vaccines
ASJC Scopus subject areas
- General Veterinary
- Public Health, Environmental and Occupational Health
- Infectious Diseases
- Molecular Medicine
- General Immunology and Microbiology